Teladoc Health (NYSE:TDOC) Trading Up 5.3%

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) rose 5.3% on Wednesday . The stock traded as high as $7.78 and last traded at $7.77. Approximately 2,210,796 shares were traded during mid-day trading, a decline of 60% from the average daily volume of 5,506,659 shares. The stock had previously closed at $7.38.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Bank of America reduced their target price on Teladoc Health from $16.50 to $13.50 and set a "neutral" rating on the stock in a research note on Tuesday, May 14th. Barclays decreased their price objective on shares of Teladoc Health from $20.00 to $10.00 and set an "overweight" rating for the company in a report on Thursday, August 1st. Truist Financial cut their target price on shares of Teladoc Health from $15.00 to $10.00 and set a "hold" rating on the stock in a research note on Friday, August 2nd. Oppenheimer decreased their price target on shares of Teladoc Health from $21.00 to $17.00 and set an "outperform" rating for the company in a research note on Thursday, August 1st. Finally, TD Cowen cut their price objective on Teladoc Health from $15.00 to $9.00 and set a "hold" rating on the stock in a research report on Thursday, August 1st. Fourteen equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $12.44.

Teladoc Health Price Performance

The firm has a 50-day moving average of $8.34 and a 200-day moving average of $11.55. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.62 and a current ratio of 1.66. The firm has a market capitalization of $1.27 billion, a P/E ratio of -5.28 and a beta of 0.90.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share for the quarter, topping the consensus estimate of ($0.36) by $0.08. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. The firm had revenue of $642.44 million during the quarter, compared to analysts' expectations of $649.34 million. As a group, analysts predict that Teladoc Health, Inc. will post -0.71 EPS for the current year.

Insider Activity

In other Teladoc Health news, CEO Laizer Kornwasser sold 10,879 shares of the business's stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $88,555.06. Following the completion of the sale, the chief executive officer now directly owns 99,929 shares in the company, valued at approximately $813,422.06. The sale was disclosed in a document filed with the SEC, which is available through this link. In related news, insider Vidya Raman-Tangella sold 3,857 shares of the firm's stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total value of $31,395.98. Following the transaction, the insider now owns 33,667 shares of the company's stock, valued at $274,049.38. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Laizer Kornwasser sold 10,879 shares of the company's stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $88,555.06. Following the sale, the chief executive officer now directly owns 99,929 shares of the company's stock, valued at $813,422.06. The disclosure for this sale can be found here. Insiders have sold a total of 57,819 shares of company stock valued at $442,204 in the last 90 days. 0.95% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Teladoc Health

A number of hedge funds have recently modified their holdings of TDOC. International Assets Investment Management LLC increased its holdings in Teladoc Health by 1,777.0% in the 4th quarter. International Assets Investment Management LLC now owns 112,038 shares of the health services provider's stock worth $2,414,000 after acquiring an additional 106,069 shares in the last quarter. CWM LLC raised its position in shares of Teladoc Health by 31.3% during the 4th quarter. CWM LLC now owns 5,416 shares of the health services provider's stock valued at $117,000 after purchasing an additional 1,291 shares during the period. Van ECK Associates Corp raised its position in shares of Teladoc Health by 20.3% during the 4th quarter. Van ECK Associates Corp now owns 3,589 shares of the health services provider's stock valued at $77,000 after purchasing an additional 606 shares during the period. Victory Capital Management Inc. lifted its stake in shares of Teladoc Health by 23.3% during the 4th quarter. Victory Capital Management Inc. now owns 22,136 shares of the health services provider's stock valued at $477,000 after buying an additional 4,190 shares in the last quarter. Finally, M&T Bank Corp boosted its holdings in Teladoc Health by 5.5% in the 4th quarter. M&T Bank Corp now owns 11,152 shares of the health services provider's stock worth $241,000 after buying an additional 584 shares during the period. Institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.